Aquaculture Vaccine Market Report 2025 (Global Edition)

Global Aquaculture Vaccine Market Report 2025 Market Size Split by Type of Vaccines (Inactivated Vaccines, Live Vaccines, Others), by Application (Bacterial Infection, Viral Infection, Others), by Rou...

Aquaculture Vaccine Market Report Description

We have various report editions of Aquaculture Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Aquaculture Vaccine Market

Key companies in the trout aquaculture vaccine market, such as Vaccitech Inc., FishVax Ltd., and AquaTraq Ltd., are engaged in fierce competition. These businesses concentrate on R&D to improve vaccination efficacy, preserve biosecurity, and guarantee adherence to local laws. Strategic alliances and cooperation further characterize the competitive landscape as businesses work to forge a solid market position and satisfy the changing needs of the aquaculture sector.

Aquaculture Vaccine Industry News

• January 2020: Barramundi Asia, a Singapore-based company, announced a merger with fellow Singaporean Allergo Aqua. The goal of the merger was to bring fingerling research and development vaccines in-house. This method aided businesses in maintaining long-term business relationships, hence enhancing their market presence.

Top Companies Market Share in Aquaculture Vaccine Industry: (In no particular order of Rank)

• Zoetis Inc.
• Merck & Co. Inc
• HIPRA
• Virbac
• Nisseiken Co. Ltd. 
• Vaxxinova International BV
• Kyoto Biken Laboratories Inc
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American Aquaculture Vaccine Gimbal Market share was 38% of the total market

According to Cognitive Market Research, North America dominated the market in 2023. It accounted for around 38% of the global revenue, owing to the region's growing beauty and cosmetics industry, influenced by trends in beauty self-expression, the impact of social media influencers, and an emphasis on product innovation. Increased online retail accessibility, the pursuit of natural and organic options, and a focus on inclusivity also contribute to the market's expansion, making it a dynamic and competitive sector within the broader cosmetics industry.

Europe is the fastest-growing category as the region's increasing influence of social media and beauty influencers, the demand for customizable and inclusive products, a growing focus on sustainability and natural ingredients, and the proliferation of e-commerce coupled with a desire for self-expression and grooming contribute to the market's sustained growth, making it a vibrant and evolving segment within the broader cosmetics industry.

The current report Scope analyzes Aquaculture Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Aquaculture Vaccine

According to Cognitive Market Research, the global Aquaculture Vaccine market size was estimated at USD 452.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 180.88 million in 2023. It will grow at a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030 due to the witnessing robust growth, driven by increasing demand for sustainable seafood, rising awareness of disease prevention in aquaculture, and stringent regulations promoting health and safety standards—technological advancements in vaccine development and a growing emphasis on responsible aquaculture practices further fuel market expansion. Increasing demand for sustainable seafood production, rising awareness of disease prevention in aquaculture, and stringent regulations promoting responsible farming practices are key drivers.

• According to Cognitive Market Research, the US had a major share in the aquaculture vaccines market, with a market size of USD 142.71 million in 2023, which is projected to grow at a CAGR of 6.9% during the forecast period. This is majorly increasing demand for sustainable seafood, raising awareness of disease prevention in fish farming, and government initiatives promoting aquaculture. 
• The Canada aquaculture vaccines market had a market share of USD 21.71 million in 2023 and is projected to grow at a CAGR of 7.9% during the forecast period. Factors such as rising awareness of disease prevention, technological advancements, and government support propel market growth.
• The Mexico aquaculture vaccines market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 16.46 million in 2023.

Europe Aquaculture Vaccine

According to Cognitive Market Research, with a market value of USD 452.2 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030, Europe accounted for a share of over 30% of the global market size of USD 135.66 million due to the increased adoption of vaccination strategies to enhance fish health and productivity is driving market expansion. Key segments include vaccines for salmonids, carp, and other commercially important species. Rising awareness of disease prevention and sustainable aquaculture practices is fostering the demand for effective vaccines. Increasing demand for sustainable seafood, rising awareness of disease prevention in fish farming, and stringent regulations promoting responsible aquaculture practices.

• According to Cognitive Market Research, the German aquaculture vaccines market size was valued at USD 26.86 million in 2023 and is projected to grow at a CAGR of 7.6% during the forecast period. This is majorly due to the Growing investments in research and development, coupled with a focus on improving aquaculture productivity, contribute to the market's expansion,
• The United Kingdom aquaculture vaccines market had a market share of USD 22.79 million in 2023 and is projected to grow at a CAGR of 8.2% during the forecast period. This is due to increasing demand for sustainable seafood production, rising awareness of disease prevention in fish farms, and government support for aquaculture development. 
• The French aquaculture vaccines market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 12.48 million in 2023.
• The Italian aquaculture vaccines market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 11.67 million in 2023.
• The Russian aquaculture vaccines market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 21.03 million in 2023.
• The Spanish aquaculture vaccines market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 11.12 million in 2023.
• The Portugal aquaculture vaccines market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 2.85 million in 2023.
• The Luxembourg aquaculture vaccines market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 4.21 million in 2023.
• The Greece aquaculture vaccines market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 1.63 million in 2023.
• The Rest of Europe's aquaculture vaccines market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD 21.03 million in 2023.

Asia Pacific Aquaculture Vaccine

According to Cognitive Market Research, the global Aquaculture Vaccine market size was estimated at USD 452.2 Million, out of which Asia Pacific held the market of more than 23% of the global revenue with a market size of USD 22.61 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030 due to the Rising demand for seafood and increased aquaculture production drive the market. Key segments include vaccines for various fish species, promoting health, and preventing diseases. The region's aquaculture industry benefits from advanced vaccine technologies, contributing to sustainable and efficient farming practices. Driven by increasing demand for sustainable seafood, raising awareness of disease prevention in aquaculture, and government initiatives promoting the industry. Technological advancements.

• According to Cognitive Market Research, the Chinese aquaculture vaccines market size was valued at USD 46.80 million in 2023 and is projected to grow at a CAGR of 10.4% during the forecast period. This is majorly due to the increasing demand for seafood, rising awareness of disease prevention, and government support. Growing aquaculture activities, coupled with concerns about disease outbreaks, fuel the market.
• The India aquaculture vaccines market had a market share of USD 12.48 million in 2023 and is projected to grow at a CAGR of 12.7% during the forecast period. This is due to the increasing demand for sustainable seafood, rising awareness of disease prevention in aquaculture, and government initiatives promoting the sector. 
• The Japan aquaculture vaccines market is projected to witness growth at a CAGR of 9.4% during the forecast period, with a market size of USD 14.35 million in 2023.
• The South Korean aquaculture vaccines market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 10.40 million in 2023.
• The Australian aquaculture vaccines market is projected to witness growth at a CAGR of 10.6% during the forecast period, with a market size of USD 5.41 million in 2023.
• The Southeast Asia aquaculture vaccines market is projected to witness growth at a CAGR of 11.9% during the forecast period, with a market size of USD 7.18 million in 2023.
• The Rest of the Asia Pacific aquaculture vaccines market is projected to witness growth at a CAGR of 10.7% during the forecast period, with a market size of USD 7.38 million in 2023.

South America Aquaculture Vaccine

According to Cognitive Market Research, the global Aquaculture vaccines market size was estimated at USD 452.2 Million, out of which the Latin America market has more than 5% of the global revenue with a market size of USD 22.61 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030 due to the rising demand for sustainable and disease-resistant aquaculture practices. Key segments include vaccines for fish species like tilapia, salmon, and shrimp. Increased awareness of disease prevention, coupled with the expansion of aquaculture activities in the region, is fueling market expansion. Increasing demand for sustainable seafood, raising awareness of disease prevention in aquaculture, and government initiatives promoting responsible aquaculture practices. Growing investments in research and development.

• According to Cognitive Market Research, the Brazil aquaculture vaccines market size was valued at USD 9.68 million in 2023 and is projected to grow at a CAGR of 8.9% during the forecast period. This is majorly due to the Growing concerns about disease outbreaks in fish populations propelling the adoption of vaccines, fostering the market's expansion in Brazil's thriving aquaculture industry.
• The Argentina aquaculture vaccines market had a market share of USD 3.80 million in 2023 and is projected to grow at a CAGR of 9.2% during the forecast period. This is due to the rising demand for sustainable seafood, increasing aquaculture production, and a focus on disease prevention and advancements in vaccine technology. 
• The Colombia aquaculture vaccines market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 2.01 million in 2023.
• The Peru aquaculture vaccines market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 1.85 million in 2023.
• The Chile aquaculture vaccines market is projected to witness growth at a CAGR of 8.6% during the forecast period, with a market size of USD 1.63 million in 2023.
• The Rest of the Latin American aquaculture vaccines market is projected to witness growth at a CAGR of 7.4% during the forecast period, with a market size of USD 3.64 million in 2023.

Middle East Aquaculture Vaccine

According to Cognitive Market Research, the global Aquaculture Vaccine market size was estimated at USD 452.2 Million, out of which the Middle East and Africa are the major markets of more than 5% of the global revenue with a market size of USD 22.61 million in 2023 and will grow at a compound annual growth rate (CAGR) of 8.3% from 2023 to 2030 due to rising demand for sustainable seafood production. Key segments include vaccines for various aquaculture species, such as fish and shrimp, aimed at preventing diseases and enhancing overall yield. The increasing awareness of the benefits of vaccination in aquaculture, coupled with government initiatives to promote the sector, is driving market expansion in the region. These factors contribute to a flourishing market for aquaculture vaccines, addressing the region's challenges in maintaining a resilient and efficient seafood supply chain.

• According to Cognitive Market Research, the GCC Countries' aquaculture vaccines market size was valued at USD 3.87 million in 2023 and is projected to grow at a CAGR of 9.4% during the forecast period. This is majorly due to the increasing demand for sustainable fish farming, rising concerns about disease outbreaks in aquaculture, and government initiatives promoting the industry. 
• The South Africa aquaculture vaccines market had a market share of USD 1.43 million in 2023 and is projected to grow at a CAGR of 9.6% during the forecast period. This is due to the rising demand for seafood, growing concerns about disease outbreaks in aquaculture, and a focus on sustainable fish farming—increased investment in research and development. 
• The Egyptian aquaculture vaccines market is projected to witness growth at a CAGR of 8.9% during the forecast period, with a market size of USD 0.95 million in 2023.
• The Turkish aquaculture vaccines market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 0.78 million in 2023.
• The Nigeria aquaculture vaccines market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 0.95 million in 2023.
• The Rest of the MEA aquaculture vaccines market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD 1.07 million in 2023.

Aquaculture Vaccine Market Analysis

Aquaculture Vaccine Type of Vaccines Segment Analysis

An increasing emphasis on sustainable aquaculture methods in Europe fueled the introduction of these vaccinations. The use of inactivated vaccines increased as a result of a surge in interest in disease prevention in North America. Aquaculture investments surged in Latin America, propelling growth in the regional market. There was a steady transition to more sophisticated disease control techniques across the Middle East and Africa. Inactivated aquaculture vaccinations were essential in each location for improving biosecurity and fostering the aquaculture sector's long-term expansion.

Live vaccines for aquaculture are becoming widely adopted, especially in countries like China and India. Advanced live vaccine technologies are becoming more and more popular in North America and Europe, where the focus is on disease prevention in aquaculture. Live vaccinations are being used more frequently in Latin America as a result of growing aquaculture activities. As a result of increased knowledge and infrastructure, adoption is moderate throughout the Middle East and Africa. The regional dynamics underscore a global trend towards live vaccines as an essential instrument for augmenting disease resistance and guaranteeing the well-being of aquacultured animals.

• Inactivated Vaccines
• Live Vaccines
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Aquaculture Vaccine Industry. Request a Free Sample PDF!

Aquaculture Vaccine Application Segment Analysis

Products that target bacterial diseases in aquaculture and are vaccines show clear patterns. Because aquaculture is so important economically, there has been a surge in the adoption of vaccines to fight common bacterial illnesses in the Asia-Pacific region. Europe places a strong emphasis on laws that encourage vaccination as a means of preventing disease. As a result of bacterial issues in salmon aquaculture, vaccination applications are increasing in North America. The aquaculture vaccine industry in South America has room to grow, with a particular emphasis on fighting bacterial diseases in prawn production. Adoption of vaccines is gradually rising across Africa and the Middle East, in line with the growing aquaculture sector and the need to manage bacterial infections.

Asia-Pacific emerges as a major player in the aquaculture vaccine market for viral diseases because of the region's substantial aquaculture industry. Demand is driven by nations like China and India, which address viral risks to prawns and fish farms. Adoption of vaccines is encouraged in Europe by strict rules and sustainable aquaculture practices. In salmon and trout farming, illness control is the main concern in North America. Latin America is seeing an increase, especially in the production of prawns and tilapia. In Africa, the use of vaccines in tilapia and catfish production has risen. Viral infection prevention through biosecurity measures is emphasized in the Middle East. Advanced aquaculture vaccination treatments, regulatory frameworks, and particular viral issues all impact regional dynamics.

• Bacterial Infection
• Viral Infection
• Others

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Aquaculture Vaccine Route of Administration Segment Analysis

Diverse trends are highlighted by a regional analysis of the aquaculture vaccine market's immersion vaccines. Rising prawn and fish farming fueled the need for immersion vaccines in Asia-Pacific, a significant industry, as well as government backing. The adoption of vaccines was influenced by the increase in sustainable aquaculture methods in Europe. With an emphasis on disease prevention in farmed species, North America saw an increase. The growing aquaculture industries aided immersion Vaccine market expansion in South America. There has been an increasing focus on biosecurity precautions throughout Africa and the Middle East. The market for immersion vaccines was largely determined by regional differences in aquaculture methods, regulatory frameworks, and industry dynamics, which represented a range of opportunities and problems.

Different patterns emerge from the regional injection vaccine analysis in the aquaculture vaccination market. Growing concerns about disease prevention have led to a rise in the use of injectable vaccines in Asia-Pacific, a significant hub for aquaculture. Demand for these vaccinations is rising in Europe as a result of strict laws that prioritize environmentally friendly aquaculture methods. A move towards injectable vaccines is observed in North America, which is indicative of an emphasis on biosecurity and disease management. The market is gradually developing in South America as a result of rising aquaculture activity. Africa is a developing market with room for the use of injectable vaccinations.

• Immersion Vassines
• Injection Vaccines
• Oral Vaccines

Aquaculture Vaccine Species Segment Analysis

Market trends for aquaculture vaccines are peculiar to certain species. There is a significant market for carp, tilapia, and prawn vaccines in Asia-Pacific, which large aquaculture producers like China dominate. The Atlantic salmon farming sector in Europe depends heavily on trout and salmonid vaccinations. In North America, there is a focus on catfish and shellfish vaccinations. The focus of vaccinations for tilapia and prawn aquaculture is Latin America. There is potential for vaccines targeting species such as catfish and tilapia in the Middle East and Africa. Regional differences draw attention to the various aquaculture methods and preferences, which affect the market for vaccines targeted at particular species on various continents.

There are regional differences in the trout aquaculture vaccine market. The substantial presence of trout farms in Europe, especially in nations like Norway and Scotland, is the driving force behind the demand for vaccinations for trout aquaculture. The region's market is influenced by North America, particularly by the United States' significant trout farming industry. Burgeoning trout farming activities are fueling the burgeoning demand in Asia-Pacific nations like China and Japan. South America offers prospects for vaccine suppliers because of its developing aquaculture sector. The aquaculture vaccine market for trout around the world is shaped by regional dynamics that are driven by things like disease prevalence, regulatory frameworks, and trout farming practices.

• Salmon
• Trout
• Tilapia
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion